Other
Preferred Stock, Shares Outstanding
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ1 2026May 5, 2026
Metric ID:
other_preferred_stock_shares_outstandingHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Range$0 – $0
Preferred Stock, Shares Outstanding at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's preferred stock, shares outstanding?
- Neurocrine Biosciences (NBIX) reported preferred stock, shares outstanding of $0 in Q1 2026.